19732 Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Notices 

dosage and frequency remaining the 

same since 2004. If granted the 

exemption, he would like to drive a 

CMV. His physician states that he is 

supportive of Mr. Green receiving an 

exemption. 

Susie B. Harvey 

Ms. Harvey is a 64 year-old class B 

CDL holder in Virginia. She has a 

history of epilepsy and has remained 

seizure free since 1985. She takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, she 

would like to drive a CMV. Her 

physician states that he is supportive of 

Ms. Harvey receiving an exemption. 

Timothy G. Huntley 

Mr. Huntley is a 40 year-old class B 

CDL holder in Maine. He has a history 

of a seizure disorder and has remained 

seizure free since 2000. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Huntley receiving an exemption. 

Robert Isaac Keen, Jr. 

Mr. Keen is a 66 year-old driver in 

Virginia. He has a history of a seizure 

disorder and has remained seizure free 

since 2012. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Keen receiving an exemption. 

Chance Joseph O’Mary 

Mr. O’Mary is a 29 year-old class A 

CDL holder in Alaska. He has a history 

of a seizure disorder and has remained 

seizure free since 2005. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. O’Mary receiving an exemption. 

Larry Todd Lintelman 

Mr. Lintelman is a 48 year-old class 

A CDL holder in Alaska. He has a 

history of seizures and has remained 

seizure free since 2012. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Lintelman receiving an exemption. 

Robert D. Richter, Sr. 

Mr. Richter is a 58 year-old driver in 

Pennsylvania. He has a history of a 

seizure disorder and has remained 

seizure free since 1976. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Richter receiving an exemption. 

Robert R. Rosebrough, Jr. 

Mr. Rosebrough is a 45 year-old class 

A CDL holder in Ohio. He has a history 

of epilepsy and has remained seizure 

free since May 2014. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

November 2014. If granted the 

exemption, he would like to drive a 

CMV. His physician states that since it 

has only been nine months since his last 

event of loss of consciousness, Mr. 

Rosebrough may drive his personal 

vehicle until he has been seizure free for 

8 years. 

Michael Scott Shumake 

Mr. Shumake is a 37 year-old driver 

in Virginia. He has a history of a seizure 

disorder and has remained seizure free 

since 2000. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2001. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Shumake receiving an exemption. 

Charles Ray Taylor 

Mr. Taylor is a 49 year-old class A 

CDL holder in Mississippi. He has a 

history of a single seizure in 2009. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since that time. If granted the 

exemption, he would like to drive a 

CMV. His physician states that he is 

supportive of Mr. Taylor receiving an 

exemption. 

Karin Hawley Wagasy 

Ms. Wagasy is a 58 year-old driver in 

Tennessee. She has a history of a seizure 

disorder and has remained seizure free 

since 1975. She takes anti-seizure 

medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, she 

would like to drive a CMV. Her 

physician states that he is supportive of 

Ms. Wagasy receiving an exemption. 

Trever A. Williams 

Mr. Williams is a 44 year-old class A 

CDL holder in Minnesota. He has a 

history of a single seizure in 1983 which 

occurred postoperatively, after a 

surgical procedure to remove a foreign 

body from his head. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2006. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Williams receiving an exemption. 

Request for Comments 

In accordance with 49 U.S.C. 31315 

and 31136(e), FMCSA requests public 

comment from all interested persons on 

the exemption applications described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

earlier in the notice. 

Issued on: April 7, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–08392 Filed 4–10–15; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[FMCSA Docket No. FMCSA–2014–0312] 

Qualification of Drivers; Exemption 

Applications; Diabetes Mellitus 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA confirms its decision 

to exempt 69 individuals from its rule 

prohibiting persons with insulin-treated 

diabetes mellitus (ITDM) from operating 

commercial motor vehicles (CMVs) in 

interstate commerce. The exemptions 

enable these individuals to operate 

CMVs in interstate commerce. 

DATES: The exemptions were effective 

on February 24, 2015. The exemptions 

expire on February 24, 2017. 

FOR FURTHER INFORMATION CONTACT: 

Charles A. Horan, III, Director, Carrier, 

Driver and Vehicle Safety Standards, 

(202) 366–4001, fmcsamedical@ dot.gov, 

FMCSA, Room W64–224, Department of 

Transportation, 1200 New Jersey 

Avenue SE., Washington, DC 20590– 

0001. Office hours are from 8:30 a.m. to 

5 p.m., Monday through Friday, except 

Federal holidays. 

SUPPLEMENTARY INFORMATION: 

I. Electronic Access 

You may see all the comments online 

through the Federal Document 

Management System (FDMS) at: http:// 

www.regulations.gov. 

Docket: For access to the docket to 

read background documents or 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Notices 19733 

comments, go to http:// 

www.regulations.gov and/or Room 

W12–140 on the ground level of the 

West Building, 1200 New Jersey Avenue 

SE., Washington, DC, between 9 a.m. 

and 5 p.m., Monday through Friday, 

except Federal holidays. 

Privacy Act: In accordance with 5 

U.S.C. 553(c), DOT solicits comments 

from the public to better inform its 

rulemaking process. DOT posts these 

comments, without edit, including any 

personal information the commenter 

provides, to www.regulations.gov, as 

described in the system of records 

notice (DOT/ALL–14 FDMS), which can 

be reviewed at www.dot.gov/privacy. 

II. Background 

On January 23, 2014, FMCSA 

published a notice of receipt of Federal 

diabetes exemption applications from 

69 individuals and requested comments 

from the public (80 FR 3724). The 

public comment period closed on 

February 23, 2015, and three comments 

were received. 

FMCSA has evaluated the eligibility 

of the 69 applicants and determined that 

granting the exemptions to these 

individuals would achieve a level of 

safety equivalent to or greater than the 

level that would be achieved by 

complying with the current regulation 

49 CFR 391.41(b)(3). 

Diabetes Mellitus and Driving 

Experience of the Applicants 

The Agency established the current 

requirement for diabetes in 1970 

because several risk studies indicated 

that drivers with diabetes had a higher 

rate of crash involvement than the 

general population. The diabetes rule 

provides that ‘‘A person is physically 

qualified to drive a commercial motor 

vehicle if that person has no established 

medical history or clinical diagnosis of 

diabetes mellitus currently requiring 

insulin for control’’ (49 CFR 

391.41(b)(3)). 

FMCSA established its diabetes 

exemption program, based on the 

Agency’s July 2000 study entitled ‘‘A 

Report to Congress on the Feasibility of 

a Program to Qualify Individuals with 

Insulin-Treated Diabetes Mellitus to 

Operate in Interstate Commerce as 

Directed by the Transportation Act for 

the 21st Century.’’ The report concluded 

that a safe and practicable protocol to 

allow some drivers with ITDM to 

operate CMVs is feasible. The 

September 3, 2003 (68 FR 52441), 

Federal Register notice in conjunction 

with the November 8, 2005 (70 FR 

67777), Federal Register notice provides 

the current protocol for allowing such 

drivers to operate CMVs in interstate 

commerce. 

These 69 applicants have had ITDM 

over a range of one to 29 years. These 

applicants report no severe 

hypoglycemic reactions resulting in loss 

of consciousness or seizure, requiring 

the assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning 

symptoms, in the past 12 months and no 

recurrent (2 or more) severe 

hypoglycemic episodes in the past 5 

years. In each case, an endocrinologist 

verified that the driver has 

demonstrated a willingness to properly 

monitor and manage his/her diabetes 

mellitus, received education related to 

diabetes management, and is on a stable 

insulin regimen. These drivers report no 

other disqualifying conditions, 

including diabetes-related 

complications. Each meets the vision 

requirement at 49 CFR 391.41(b)(10). 

The qualifications and medical 

condition of each applicant were stated 

and discussed in detail in the January 

23, 2014, Federal Register notice and 

they will not be repeated in this notice. 

III. Discussion of Comments 

FMCSA received three comments in 

this proceeding. The comments are 

discussed below. 

The American Trucking Associations, 

Inc. (ATA) submitted a comment 

stating, ‘‘ATA believes that the 

increased volume of applications for 

exemption from parts of 49 CFR 391.41 

is cause for concern. The granting of 

such a large number of exemptions 

dilutes the physical qualification 

standards and constitutes regulation 

through exemption. FMCSA must begin 

a dialogue on the need and effectiveness 

of these standards. If it is determined 

that these standards need to be altered, 

it must be done through the formal 

rulemaking process.’’ FMCSA is 

engaged in a formal rulemaking process, 

and is preparing to publish an NPRM in 

the spring of this year. 

Scott Cleveland submitted a comment 

stating the Federal Register notice did 

not tell him if he was approved. As 

stated in the notice, all drivers listed 

will receive an exemption effective the 

day after the close of the request for 

comments period, barring any negative 

comments. 

An anonymous commenter submitted 

a comment stating that the Federal 

Register notice requesting comments 

does not state whether people are being 

granted an exemption because the 

comment period must end before the 

final determination is made. 

IV. Basis for Exemption Determination 

Under 49 U.S.C. 31136(e) and 31315, 

FMCSA may grant an exemption from 

the diabetes requirement in 49 CFR 

391.41(b)(3) if the exemption is likely to 

achieve an equivalent or greater level of 

safety than would be achieved without 

the exemption. The exemption allows 

the applicants to operate CMVs in 

interstate commerce. 

To evaluate the effect of these 

exemptions on safety, FMCSA 

considered medical reports about the 

applicants’ ITDM and vision, and 

reviewed the treating endocrinologists’ 

medical opinion related to the ability of 

the driver to safely operate a CMV while 

using insulin. 

Consequently, FMCSA finds that in 

each case exempting these applicants 

from the diabetes requirement in 49 CFR 

391.41(b)(3) is likely to achieve a level 

of safety equal to that existing without 

the exemption. 

V. Conditions and Requirements 

The terms and conditions of the 

exemption will be provided to the 

applicants in the exemption document 

and they include the following: (1) That 

each individual submit a quarterly 

monitoring checklist completed by the 

treating endocrinologist as well as an 

annual checklist with a comprehensive 

medical evaluation; (2) that each 

individual reports within 2 business 

days of occurrence, all episodes of 

severe hypoglycemia, significant 

complications, or inability to manage 

diabetes; also, any involvement in an 

accident or any other adverse event in 

a CMV or personal vehicle, whether or 

not it is related to an episode of 

hypoglycemia; (3) that each individual 

provide a copy of the ophthalmologist’s 

or optometrist’s report to the medical 

examiner at the time of the annual 

medical examination; and (4) that each 

individual provide a copy of the annual 

medical certification to the employer for 

retention in the driver’s qualification 

file, or keep a copy in his/her driver’s 

qualification file if he/she is selfemployed. The driver must also have a 

copy of the certification when driving, 

for presentation to a duly authorized 

Federal, State, or local enforcement 

official. 

VI. Conclusion 

Based upon its evaluation of the 69 

exemption applications, FMCSA 

exempts the following drivers from the 

diabetes requirement in 49 CFR 

391.41(b)(10), subject to the 

requirements cited above 949 CFR 

391.64(b)): 

mstockstill on DSK4VPTVN1PROD with NOTICES

19734 Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Notices 

Bryan L. Anderson (WA), Travis K. 

Archer (ME), Michael R. Batham (CA), 

Victor M. Beltran-Araujo (ID), Charles 

A. Best (OH), Cassandra J. Braford 

(MN), Mark E. Buchholz (SD), Richard 

E. Buthy (NJ), George E. Carle (CO), 

Jamey S. Carney (IA), Bryan D. 

Carpenter (NC), Michael G. Cary 

(MN), John G. Castilaw (MS), 

Dominick Cicala (NJ), Scott E. 

Clevelan (KY), Adam C. Cochran 

(GA), Michael R. Cummings (VA), 

David L. Dalheim (NY), Brian Dick 

(MD), Timothy B. Duelke (ID), Cory A. 

Duncan (OR), Terrence J. Dunne (NJ), 

David L. Eklund (IL), Yoshitsugu 

Endo (NY), Barry K. Foster (TX), 

Robert Fugate (OH), John A. Georg 

(IA), Francis J. Gernatt, Jr. (NY), Mark 

A. Haines (WV), Ivan G. Hanford 

(OR), James L. Harman, III (VA), James 

R. Hoyle (TX), George E. Huften (CT), 

John M. Ippolito (NY), Allan L. 

Jameson (NE), Erik D. Kemmer (MN), 

Mark L. Knobel, Sr. (MD), Joseph E. 

Knox, Sr., Erik M. Lane (NY), Jacob C. 

Liebl (ND), Galen H. Martin (PA), 

James D. Martin (IN), John M. McCabe 

(IL), Kevin F. McGlade (PA), Brett J. 

Mellor (ID), Kenneth M. Merritt (CA), 

Douglas D. Milligan (WA), Charles E. 

Morgan (LA), Richard D. Neal (TN), 

Gary Anthony Alfred H. Nelson (FL), 

Robert E. Perdue (WA), Christie M. 

Rose (TX), John E. Sautkulis (NY), 

Kevin D. Schlichting (PA), Ronnie L. 

Schronce (NC), Richard A. Sharpe 

(MN), William F. Smith (DE), Richard 

W. Stultz (IN), Robin W. Swasey (UT), 

Michelle P. Thibeault (ME), Michael 

L. Thrasher (AL), Melinda K. Topel 

(MO), Steven R. Vance (TX), William 

D. VanReese (MN), Ellis J. Vest, Jr. 

(WV), Herbert E. Wachtel (MN), 

Kendall G. Webster (OR), Christopher 

J. Wilson (PA), Mark P. Zimmerman 

(NV). 

In accordance with 49 U.S.C. 31136(e) 

and 31315 each exemption is valid for 

two years unless revoked earlier by 

FMCSA. The exemption will be revoked 

if the following occurs: (1) The person 

fails to comply with the terms and 

conditions of the exemption; (2) the 

exemption has resulted in a lower level 

of safety than was maintained before it 

was granted; or (3) continuation of the 

exemption would not be consistent with 

the goals and objectives of 49 U.S.C. 

31136(e) and 31315. If the exemption is 

still effective at the end of the 2-year 

period, the person may apply to FMCSA 

for a renewal under procedures in effect 

at that time. 

Issued on: April 3, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–08413 Filed 4–10–15; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Pipeline and Hazardous Materials 

Safety Administration 

[Docket No. PHMSA–2014–0014] 

Pipeline Safety: Public Workshop on 

Pipeline Safety Management Systems 

Correction 

In notice document 2015–08115 

appearing on pages 19113–19114 in the 

issue of April 9, 2015, make the 

following correction: 

On page 19113, in the second column, 

under the DATES heading, in the third 

line, ‘‘8:00 a.m. to 4:30 p.m. EST’’ 

should read ‘‘8:00 a.m. to 4:30 p.m. 

CST’’. 

[FR Doc. C1–2015–08115 Filed 4–9–15; 4:15 pm] 

BILLING CODE 1505–01–D 

DEPARTMENT OF TRANSPORTATION 

Intelligent Transportation Systems 

Program Advisory Committee; Notice 

of Meeting 

AGENCY: ITS Joint Program Office, Office 

of the Assistant Secretary for Research 

and Technology, U.S. Department of 

Transportation. 

ACTION: Notice. 

The Intelligent Transportation 

Systems (ITS) Program Advisory 

Committee (ITSPAC) will hold a 

teleconference on May 13, 2015, from 

1:00 p.m. to 2:00 p.m. (EDT). 

The ITSPAC, established under 

Section 5305 of Public Law 109–59, 

Safe, Accountable, Flexible, Efficient 

Transportation Equity Act: A Legacy for 

Users, August 10, 2005, and reestablished under Section 53003 of 

Public Law 112–141, Moving Ahead for 

Progress in the 21st Century, July 6, 

2012, was created to advise the 

Secretary of Transportation on all 

matters relating to the study, 

development, and implementation of 

intelligent transportation systems. 

Through its sponsor, the ITS Joint 

Program Office (JPO), the ITSPAC makes 

recommendations to the Secretary 

regarding ITS Program needs, objectives, 

plans, approaches, content, and 

progress. 

The following is a summary of the 

meeting tentative agenda: (1) Welcome, 

(2) Meeting Purpose, (3) Subcommittee 

Updates, (4) Review Action Items, (5) 

Summary and Adjourn. 

The teleconference will be open to the 

public, but limited conference lines will 

be available on a first-come, first-served 

basis. Members of the public who wish 

to participate in the teleconference must 

submit a request to ITSPAC@dot.gov, 

not later than May 6, 2015. In addition, 

for planning purposes, your request 

must also indicate whether you wish to 

present oral statements during the 

teleconference. 

Questions about the agenda or written 

comments may be submitted by U.S. 

Mail to: U.S. Department of 

Transportation, Office of the Assistant 

Secretary for Research and Technology, 

ITS Joint Program Office, Attention: 

Stephen Glasscock, 1200 New Jersey 

Avenue SE., HOIT, Washington, DC 

20590 or faxed to (202) 493–2027. The 

ITS JPO requests that written comments 

be submitted not later than May 6, 2015. 

Notice of this teleconference is 

provided in accordance with the Federal 

Advisory Committee Act and the 

General Services Administration 

regulations (41 CFR part 102–3) 

covering management of Federal 

advisory committees. 

Issued in Washington, DC, on the 8 day of 

April, 2015. 

Stephen Glasscock, 

Designated Federal Official, ITS Joint 

Program Office. 

[FR Doc. 2015–08403 Filed 4–10–15; 8:45 am] 

BILLING CODE 4910–22–P 

DEPARTMENT OF THE TREASURY 

Office of the Comptroller of the 

Currency 

[Docket ID OCC–2015–0002] 

Mutual Savings Association Advisory 

Committee 

AGENCY: Office of the Comptroller of the 

Currency, Department of the Treasury. 

ACTION: Notice of Federal Advisory 

Committee Meeting. 

SUMMARY: The Office of the Comptroller 

of the Currency (OCC) announces a 

meeting of the Mutual Savings 

Association Advisory Committee 

(MSAAC). 

DATES: A public meeting of the MSAAC 

will be held on Tuesday, April 28, 2015, 

beginning at 8:00 a.m. Eastern Daylight 

Time (EDT). Members of the public may 

submit written statements to the 

MSAAC. The OCC must receive written 

statements no later than Thursday, April 

23, 2015. Members of the public who 

plan to attend the meeting, and 

mstockstill on DSK4VPTVN1PROD with NOTICES